Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein

This publication has 23 references indexed in Scilit:

• Clinical link between MHC class II haplotype and interferon-beta (IFN-β) immunogenicity
  Clinical Immunology, 2006
• From genome to vaccine—new immunoinformatics tools for vaccine design
  Methods, 2004
• Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
  Cancer Cell, 2004
• An In Vitro Human Cell-Based Assay to Rank the Relative Immunogenicity of Proteins
  Toxicological Sciences, 2004
• Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach
  Vaccine, 2003
• Validation of the BIACORE 3000 platform for detection of antibodies against erythropoietic agents in human serum samples
  Current Medical Research and Opinion, 2003
• Immuno‐informatics: Mining genomes for vaccine components
  Immunology & Cell Biology, 2002
• Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
  New England Journal of Medicine, 2002
• Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix
  Vaccine, 1998
• Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells
  European Journal of Immunology, 1989